SCHEMBL14566356

SCHEMBL14566356

CCCCOCC(C)(C)C(=O)SCCOC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14566362 0.90 MEN1 (0.30) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14566375 0.85 GAA (0.34) TSHRALDH1A1HDAC3HDAC4HDAC1
SCHEMBL14566355 0.83 FDPS (0.32) TSHRCYP3A4ALDH1A1MAPTHDAC3
SCHEMBL14566492 0.83 MEN1 (0.33) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14566424 0.82 KDM4E (0.36) TSHRCYP3A4MAPT
SCHEMBL21957514 0.81 CES1 (0.37) CES2CES1ALDH1A1HCAR2PTGS2
SCHEMBL14566422 0.81 KDM4E (0.38) TSHRCES2CYP3A4MAPT
SCHEMBL14566351 0.80 HDAC3 (0.34) ALDH1A1HSD17B10HDAC3HDAC4HDAC1
SCHEMBL14566406 0.79 MEN1 (0.33) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14566335 0.79 ALDH1A1 (0.33) TSHRCYP3A4HPGDALDH1A1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007027248-A2 3', 5' - CYCLIC NUCLEOSIDE ANALOGUES FOR TREATMENT OF HCV VALEANT RESEARCH & DEVELOPMENT (US) 2007-03-08 WO disclosed